AGING

• Platelet activation is caused not by aging but by atherosclerosis.
  (Kurabayashi H, et al. Arch Gerontol Geriatr. 2009 Nov 20. [Epub ahead of print])
  View Abstract
• Modification of the Effect of Glycemic Status on Aortic Distensibility by Age in the Multi-Ethnic Study of Atherosclerosis.
  (Stacey RB, et al. Hypertension. 2009 Nov 23. [Epub ahead of print])
  View Abstract

APO/LIPOPROTEINS

• Characteristics of apolipoprotein M and its relation to atherosclerosis and diabetes.
  (Hu YW, et al. Biochim Biophys Acta. 2009 Nov 10. [Epub ahead of print])
  View Abstract

BIOMARKERS

• Effects of bariatric surgery on inflammatory, functional and structural markers of coronary atherosclerosis.
  (Habib P, et al. Am J Cardiol. 2009 Nov 1;104(9):1251-5.)
  View Abstract
• Prognostic accuracy of B-natriuretic peptide measurements and coronary artery calcium in asymptomatic subjects (from the Early Identification of Subclinical Atherosclerosis by Noninvasive Imaging Research [EISNER] study).
  (Shaw LJ, et al. Am J Cardiol. 2009 Nov 1;104(9):1245-50.)
  View Abstract

DIET, NUTRITION, AND METABOLISM

• Safflower seed polyphenols (N-(p-coumaroyl)serotonin and N-feruloylserotonin) ameliorate atherosclerosis and distensibility of the aortic wall in Kurosawa and Kusanagi-hypercholesterolemic (KHC) rabbits.
  (Katsuda S, et al. Hypertens Res. 2009 Nov;32(11):944-9. Epub 2009 Sep 18.)
  View Abstract

DRUG THERAPY

• Effect of rosuvastatin on coronary atheroma in stable coronary artery disease: multicenter coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese subjects (COSMOS).
  (Takayama T, et al. Circ J. 2009 Nov;73(11):2110-7. Epub 2009 Oct 5.)
  View Abstract
• Heparin inhibits the production of matrix metalloproteinase-2 and improves atherosclerosis in LDL receptor-deficient mice.
  (Guo H, et al. Coron Artery Dis. 2009 Nov 24. [Epub ahead of print])
  View Abstract
• Preventive effect of a proteasome inhibitor on the formation of accelerated atherosclerosis in rabbits with uremia.
  (Bing F, et al. J Cardiovasc Pharmacol. 2009 Nov 20. [Epub ahead of print])
  View Abstract
• Effect of Lovastatin on Primary Prevention of Cardiovascular Events in Mild CKD and Kidney Function Loss: A Post Hoc Analysis of the Air Force/Texas Coronary Atherosclerosis Prevention Study.
  (Kendrick J, et al. Am J Kidney Dis. 2009 Nov 20. [Epub ahead of print])
  View Abstract
• Oral rapamycin attenuates atherosclerosis without affecting the arterial responsiveness of resistance vessels in apolipoprotein E-deficient mice.
  (Gadioli AL, et al. Braz J Med Biol Res. 2009 Dec;42(12):1191-5. Epub 2009 Nov 6.)
  View Abstract
• Total panax notoginsenosides prevent atherosclerosis in apolipoprotein E-knockout mice: Role of downregulation of CD40 and MMP-9 expression.
  (Liu G, et al. J Ethnopharmacol. 2009 Nov 12;126(2):350-4. Epub 2009 Aug 22.)
  View Abstract
• Effects of high-dose modified-release nicotinic acid on atherosclerosis and vascular function: a randomized, placebo-controlled, magnetic resonance imaging study.
  (Lee JM, et al. J Am Coll Cardiol. 2009 Nov 3;54(19):1787-94.)
  View Abstract
• 7-Difluoromethyl-5,4'-dimethoxygenistein, a novel genistein derivative, has therapeutic effects on atherosclerosis in a rabbit model.
  (Zhao H, et al. J Cardiovasc Pharmacol. 2009 Nov;54(5):412-20.)
  View Abstract
• Proteomic profiling during atherosclerosis progression: Effect of nebivolol treatment.
  (Ozben B, et al. Mol Cell Biochem. 2009 Nov;331(1-2):9-17. Epub 2009 May 7.)
  View Abstract

EPIDEMIOLOGY

• Prevalence and Correlates of Diabetes in South Asian Indians in the United States: Findings From the Metabolic Syndrome and Atherosclerosis in South Asians Living in America and Multi-Ethnic Study of Atherosclerosis Studies.
  (Kanaya AM, et al. Metab Syndr Relat Disord. 2009 Nov 29. [Epub ahead of print])
  View Abstract

GENETICS OF CARDIOVASCULAR DISEASE

• Genetic Association and Interaction Analysis of USF1 and APOA5 on Lipid Levels and Atherosclerosis.
  (Laurila PP, et al. Arterioscler Thromb Vasc Biol. 2009 Nov 12. [Epub ahead of print])
  View Abstract
• Decreased expression of klotho gene in uremic atherosclerosis in apolipoprotein E-deficient mice.
  (Yu J, et al. Biochem Biophys Res Commun. 2009 Nov 11. [Epub ahead of print])
  View Abstract
• Candidate loci for insulin sensitivity and disposition index from a genome-wide association analysis of Hispanic participants in the Insulin Resistance Atherosclerosis (IRAS) Family Study.
  (Palmer ND, et al. Diabetologia. 2009 Nov 10. [Epub ahead of print])
  View Abstract
• NOS1AP variant associated with incidence of type 2 diabetes in calcium channel blocker users in the Atherosclerosis Risk in Communities (ARIC) study.
  (Chu AY, et al. Diabetologia. 2009 Nov 27. [Epub ahead of print])
  View Abstract

GENDER

• Low bone mineral density is not associated with angiographically determined coronary atherosclerosis in men.
  (Beer S, et al. Osteoporos Int. 2009 Nov 21. [Epub ahead of print])
  View Abstract

HYPERTENSION

• Geographic Variation in Hypertension Prevalence Among Blacks and Whites: The Multi-Ethnic Study of Atherosclerosis.
  (Kershaw KN, et al. Am J Hypertens. 2009 Nov 12. [Epub ahead of print])
  View Abstract
• Structural and Functional Vascular Alterations and Incident Hypertension in Normotensive Adults: The Multi-Ethnic Study of Atherosclerosis.
  (Peralta CA, et al. Am J Epidemiol. 2009 Nov 30. [Epub ahead of print])
  View Abstract
• Orthostatic Hypotension and Cognitive Function: The Atherosclerosis Risk in Communities Study.
  (Rose KM, et al. Neuroepidemiology. 2009 Nov 5;34(1):1-7. [Epub ahead of print])
  View Abstract

IMAGING

• Comparison of 3D-diffusion-prepared segmented steady-state free precession and 2D fast spin echo imaging of femoral artery atherosclerosis.
  (Hayashi K, et al. Int J Cardiovasc Imaging. 2009 Nov 28. [Epub ahead of print])
  View Abstract
• Gadolinium-containing phosphatidylserine liposomes for molecular imaging of atherosclerosis.
  (Maiseyeu A, et al. J Lipid Res. 2009 Nov;50(11):2157-63. Epub 2008 Nov 17.)
  View Abstract
• Pericardial fat is more abundant in patients with coronary atherosclerosis and even in the non-obese patients: evaluation with cardiac CT angiography.
  (Yong HS, et al. Int J Cardiovasc Imaging. 2009 Nov 24. [Epub ahead of print])
  View Abstract
• Indices of systemic atherosclerosis are superior to ultrasound resistance indices for prediction of allograft survival.
  (Gerhart MK, et al. Nephrol Dial Transplant. 2009 Nov 26. [Epub ahead of print])
  View Abstract
• Three-dimensional ultrasound quantification of intensive statin treatment of carotid atherosclerosis.
  (Krasinski A, et al. Ultrasound Med Biol. 2009 Nov;35(11):1763-72. Epub 2009 Aug 3.)
  View Abstract
• High-density lipoprotein and progression rate of atherosclerosis in intravascular ultrasound trials.
  (Nicholls SJ. Am J Cardiol. 2009 Nov 16;104(10 Suppl):16E-21E.)
  View Abstract
• High-Affinity alphavbeta3 Integrin Targeted Optical Probe as a New Imaging Biomarker for Early Atherosclerosis: Initial Studies in Watanabe Rabbits.
  (Heroux J, et al. Mol Imaging Biol. 2009 Nov 7. [Epub ahead of print])
  View Abstract
• Expert review document on methodology, terminology, and clinical applications of optical coherence tomography: physical principles, methodology of image acquisition, and clinical application for assessment of coronary arteries and atherosclerosis.
  (Prati F, et al. Eur Heart J. 2009 Nov 4. [Epub ahead of print])
  View Abstract

IMMUNOLOGY

• Regulation of cellular immunity prevents Helicobacter pylori-induced atherosclerosis.
  (Ayada K, et al. Lupus. 2009 Nov;18(13):1154-68.)
  View Abstract
• Immune-mediated mechanisms of endothelial damage in atherosclerosis.
  (Foteinos G, et al. Autoimmunity. 2009 Nov;42(7):627-33.)
  View Abstract
• Autoimmunity, infectious immunity, and atherosclerosis.
  (Matsuura E, et al. J Clin Immunol. 2009 Nov;29(6):714-21.)
  View Abstract
• Vaccination, atherosclerosis and systemic lupus erythematosus.
  (Carvalho JF, et al. Lupus. 2009 Nov;18(13):1209-12.)
  View Abstract
• HIV positivity, protease inhibitor exposure and subclinical atherosclerosis: a systematic review and meta-analysis of observational studies.
  (Hulten E, et al. Heart. 2009 Nov;95(22):1826-35. Epub 2009 Jul 23.)
  View Abstract
• Vaccination using oxidized low-density lipoprotein-pulsed dendritic cells reduces atherosclerosis in LDL receptor-deficient mice.
  (Habets KL, et al. Cardiovasc Res. 2009 Nov 12. [Epub ahead of print])
  View Abstract
• Dendritic cells pulsed with malondialdehyde modified low density lipoprotein aggravate atherosclerosis in Apoe(-/-) mice.
  (Hjerpe C, et al. Atherosclerosis. 2009 Nov 6. [Epub ahead of print])
  View Abstract
• Oral anti-CD3 antibody treatment induces regulatory T cells and inhibits the development of atherosclerosis in mice.
  (Sasaki N, et al. Circulation. 2009 Nov 17;120(20):1996-2005. Epub 2009 Nov 2.)
  View Abstract
• Expression of matrix metalloproteinase-1 mRNA in peripheral blood mononuclear cells of systemic lupus erythematosus patients and its relationship with atherosclerosis.
  (Zhang HY, et al. Chin Med J (Engl). 2009 Nov 5;122(21):2593-7.)
  View Abstract

INFLAMMATION

• Early life origins of low-grade inflammation and atherosclerosis risk in children and adolescents.
  (Labayen I, et al. J Pediatr. 2009 Nov;155(5):673-7.)
  View Abstract
• The vicious circle between oxidative stress and inflammation in atherosclerosis.
  (Hulsmans M, et al. J Cell Mol Med. 2009 Nov 28. [Epub ahead of print])
  View Abstract
• Toll-Like Receptor-2 Mediates Inflammation and Matrix Degradation in Human Atherosclerosis.
  (Monaco C, et al. Circulation. 2009 Nov 30. [Epub ahead of print])
  View Abstract
• Absence of Myeloid COX-2 Attenuates Acute Inflammation but Does Not Influence Development of Atherosclerosis in Apolipoprotein E Null Mice.
  (Narasimha AJ, et al. Arterioscler Thromb Vasc Biol. 2009 Nov 19. [Epub ahead of print])
  View Abstract
• Increased atherosclerosis and vascular inflammation in APP transgenic mice with apolipoprotein E deficiency.
  (Tibolla G, et al. Atherosclerosis. 2009 Nov 10. [Epub ahead of print])
  View Abstract
• Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis.
  (Rho YH, et al. Arthritis Rheum. 2009 Nov 15;61(11):1580-5.)
  View Abstract

LIFESTYLE

• Land use, residential density, and walking the multi-ethnic study of atherosclerosis.
  (Rodríguez DA, et al. Am J Prev Med. 2009 Nov;37(5):397-404.)
  View Abstract

LIPID AND LIPOPROTEIN METABOLISM

• Reducing endoplasmic reticulum stress through a macrophage lipid chaperone alleviates atherosclerosis.
  (Erbay E, et al. Nat Med. 2009 Dec;15(12):1383-91. Epub 2009 Nov 29.)
  View Abstract
• Hexarelin suppresses high lipid diet and vitamin D(3)-induced atherosclerosis in the rat.
  (Pang J, et al. Peptides. 2009 Nov 29. [Epub ahead of print])
  View Abstract
• Resident Intimal Dendritic Cells Accumulate Lipid and Contribute to the Initiation of Atherosclerosis.
  (Paulson KE, et al. Circ Res. 2009 Nov 5. [Epub ahead of print])
  View Abstract
• The diameter of liver sinusoidal fenestrae is not a major determinant of lipoprotein levels and atherosclerosis in cholesterol-fed rabbits.
  (Jacobs F, et al. Cardiovasc Pathol. 2009 Nov 13. [Epub ahead of print])
  View Abstract

OBESITY

• The differential association between various anthropometric indices of obesity and subclinical atherosclerosis.
  (Yan RT, et al. Atherosclerosis. 2009 Nov;207(1):232-8. Epub 2009 Apr 16.)
  View Abstract

OXIDATIVE STRESS / ANTIOXIDANTS

• Overexpression of antioxidant enzymes in ApoE-deficient mice suppresses Benzo(a)pyrene-accelerated atherosclerosis.
  (Yang H, et al. Atherosclerosis. 2009 Nov;207(1):51-8. Epub 2009 Apr 11.)
  View Abstract

PEDIATRICS

• Noninvasive assessment of subclinical atherosclerosis in children and adolescents: recommendations for standard assessment for clinical research: a scientific statement from the American Heart Association.
  (Urbina EM, et al. Hypertension. 2009 Nov;54(5):919-50. Epub 2009 Sep 3.)
  View Abstract
• "Vascular Age" is Advanced in Children with Atherosclerosis Promoting Risk Factors.
  (Le J, et al. Circ Cardiovasc Imaging. 2009 Nov 17. [Epub ahead of print])
  View Abstract

PLAQUE BIOLOGY

• Circulating smooth muscle progenitor cells in atherosclerosis and plaque rupture: Current perspective and methods of analysis.
  (Bentzon JF, et al. Vascul Pharmacol. 2009 Nov 29. [Epub ahead of print])
  View Abstract
• The Neuropeptide Substance P Mediates Adventitial Mast Cell Activation and Induces Intraplaque Hemorrhage in Advanced Atherosclerosis.
  (Bot I, et al. Circ Res. 2009 Nov 19. [Epub ahead of print])
  View Abstract

RENAL DISEASE

• Subclinical atherosclerosis and related risk factors in renal transplant recipients.
  (Basiratnia M, et al. Pediatr Nephrol. 2009 Nov 13. [Epub ahead of print])
  View Abstract
• Risk of Incident ESRD: A Comprehensive Look at Cardiovascular Risk Factors and 17 Years of Follow-up in the Atherosclerosis Risk in Communities (ARIC) Study.
  (Bash LD, et al. Am J Kidney Dis. 2009 Nov 20. [Epub ahead of print])
  View Abstract
• Circulating soluble receptor of advanced glycation end product inversely correlates with atherosclerosis in patients with chronic kidney disease.
  (Basta G, et al. Kidney Int. 2009 Nov 18. [Epub ahead of print])
  View Abstract
• Sugar-sweetened beverage consumption and the progression of chronic kidney disease in the Multi-Ethnic Study of Atherosclerosis (MESA).
  (Bomback AS, et al. Am J Clin Nutr. 2009 Nov;90(5):1172-8. Epub 2009 Sep 9.)
  View Abstract
• Contribution of subcutaneous fat accumulation to insulin resistance and atherosclerosis in haemodialysis patients.
  (Gotoh H, et al. Nephrol Dial Transplant. 2009 Nov;24(11):3474-80. Epub 2009 Jun 17.)
  View Abstract

RISK FACTORS

• Ethnicity and risk factors for change in the ankle-brachial index: the Multi-Ethnic Study of Atherosclerosis.
  (Allison MA, et al. J Vasc Surg. 2009 Nov;50(5):1049-56. Epub 2009 Jul 22.)
  View Abstract
• Risk of dementia hospitalisation associated with cardiovascular risk factors in midlife and older age: the Atherosclerosis Risk in Communities (ARIC) study.
  (Alonso A, et al. J Neurol Neurosurg Psychiatry. 2009 Nov;80(11):1194-201. Epub 2009 Aug 19.)
  View Abstract
• Influence of body mass index on extent of coronary atherosclerosis and cardiac events in a cohort of patients at risk of coronary artery disease.
  (Rossi R, et al. Nutr Metab Cardiovasc Dis. 2009 Nov 23. [Epub ahead of print])
  View Abstract
• Management of risk factors for accelerated atherosclerosis.
  (Song S, et al. Curr Treat Options Neurol. 2009 Nov;11(6):460-72.)
  View Abstract
• Subclinical atherosclerosis in patients with chronic psoriasis: a potential association.
  (El-Mongy S, et al. J Eur Acad Dermatol Venereol. 2009 Nov 2. [Epub ahead of print])
  View Abstract
• Subclinical atherosclerosis and endothelial dysfunction in young South-Asian patients with systemic lupus erythematosus.
  (Ghosh P, et al. Clin Rheumatol. 2009 Nov;28(11):1259-65. Epub 2009 Jul 19.)
  View Abstract
• The high prevalence of subclinical atherosclerosis in patients with ankylosing spondylitis without clinically evident cardiovascular disease.
  (Gonzalez-Juanatey C, et al. Medicine (Baltimore). 2009 Nov;88(6):358-65.)
  View Abstract

STROKE

• Blood Pressure and White-Matter Disease Progression in a Biethnic Cohort. Atherosclerosis Risk in Communities (ARIC) Study.
  (Gottesman RF, et al. Stroke. 2009 Nov 19. [Epub ahead of print])
  View Abstract
• Heat-shock protein 90: a novel autoantigen in human carotid atherosclerosis.
  (Businaro R, et al. Atherosclerosis. 2009 Nov;207(1):74-83. Epub 2009 May 4.)
  View Abstract
• Elevated one-hour post-load plasma glucose levels identifies subjects with normal glucose tolerance but early carotid atherosclerosis.
  (Succurro E, et al. Atherosclerosis. 2009 Nov;207(1):245-9. Epub 2009 Apr 11.)
  View Abstract
• Proteomic study of macrophages exposed to oxLDL identifies a CAPG polymorphism associated with carotid atherosclerosis.
  (Burillo E, et al. Atherosclerosis. 2009 Nov;207(1):32-7. Epub 2009 Apr 16.)
  View Abstract
• Association of high body lead store with severe intracranial carotid atherosclerosis.
  (Lee TH, et al. Neurotoxicology. 2009 Nov;30(6):876-80. Epub 2009 Jul 16.)
  View Abstract
• Low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio as a useful marker for early-stage carotid atherosclerosis.
  (Tamada M, et al. Metabolism. 2009 Nov 13. [Epub ahead of print])
  View Abstract
• Hand osteoarthritis in older women is associated with carotid and coronary atherosclerosis: the AGES Reykjavik study.
  (Jonsson H, et al. Ann Rheum Dis. 2009 Nov;68(11):1696-700. Epub 2008 Nov 25.)
  View Abstract

THROMBOSIS / HAEMOSTASIS

• Tissue factor pathway inhibitor, vascular risk factors and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis.
  (Mitchell CT, et al. Atherosclerosis. 2009 Nov;207(1):277-83. Epub 2009 Apr 24.)
  View Abstract

VASCULAR BIOLOGY

• Pathogenesis and pathophysiology of accelerated atherosclerosis in the diabetic heart.
  (D'Souza A, et al. Mol Cell Biochem. 2009 Nov;331(1-2):89-116. Epub 2009 May 23.)
  View Abstract
• Human C-reactive protein does not promote atherosclerosis in transgenic rabbits.
  (Koike T, et al. Circulation. 2009 Nov 24;120(21):2088-94. Epub 2009 Nov 9.)
  View Abstract
• The CD163-expressing macrophages recognize and internalize TWEAK: potential consequences in atherosclerosis.
  (Moreno JA, et al. Atherosclerosis. 2009 Nov;207(1):103-10. Epub 2009 May 4.)
  View Abstract
• NADPH Oxidases and Atherosclerosis: Unraveling the Details.
  (Runge MS, et al. Am J Physiol Heart Circ Physiol. 2009 Nov 6. [Epub ahead of print])
  View Abstract
• Blood glutathione and subclinical atherosclerosis in African men: the SABPA Study.
  (Schutte R, et al. Am J Hypertens. 2009 Nov;22(11):1154-9. Epub 2009 Sep 3.)
  View Abstract
• Functional alterations of myeloid cell subsets in hyperlipidemia: relevance for atherosclerosis.
  (Soehnlein O, et al. J Cell Mol Med. 2009 Nov 9. [Epub ahead of print])
  View Abstract
• Androgen deficiency and atherosclerosis: The lipid link.
  (Traish AM, et al. Vascul Pharmacol. 2009 Nov-Dec;51(5-6):303-13. Epub 2009 Oct 6.)
  View Abstract
• Lack of tyrosylprotein sulfotransferase activity in hematopoietic cells drastically attenuates atherosclerosis in Ldlr-/- mice.
  (Westmuckett AD, et al. Arterioscler Thromb Vasc Biol. 2009 Nov;29(11):1730-6. Epub 2009 Aug 13.)
  View Abstract
• Regulated expression of endothelial lipase in atherosclerosis.
  (Wu X, et al. Mol Cell Endocrinol. 2009 Nov 18. [Epub ahead of print])
  View Abstract
• Common pathogenic features of atherosclerosis and calcific aortic stenosis: role of transforming growth factor-beta.
  (Xu S, et al. Cardiovasc Pathol. 2009 Nov 25. [Epub ahead of print])
  View Abstract
• Lipoic acid effects on established atherosclerosis.
  (Ying Z, et al. Life Sci. 2009 Nov 26. [Epub ahead of print])
  View Abstract
• Hyperhomocysteinemia promotes inflammatory monocyte generation and accelerates atherosclerosis in transgenic cystathionine beta-synthase-deficient mice.
  (Zhang D, et al. Circulation. 2009 Nov 10;120(19):1893-902. Epub 2009 Oct 26.)
  View Abstract
• {beta}2 integrins modulate the initiation and progression of atherosclerosis in low-density lipoprotein receptor knockout mice.
  (Merched A, et al. Cardiovasc Res. 2009 Nov 21. [Epub ahead of print])
  View Abstract
• Heterogeneity of atherosclerosis in mesenteric arteries and outgrowth remodeling.
  (Schnee S, et al. Cardiovasc Pathol. 2009 Nov 17. [Epub ahead of print])
  View Abstract
• Chymase activity is closely related with plaque vulnerability in a hamster model of atherosclerosis.
  (Guo T, et al. Atherosclerosis. 2009 Nov;207(1):59-67. Epub 2009 Apr 17.)
  View Abstract

VASCULAR CALCIFICATION

• Calcification in atherosclerosis.
  (Alexopoulos N, et al. Nat Rev Cardiol. 2009 Nov;6(11):681-8. Epub 2009 Sep 29.)
  View Abstract
• Integrative Predictive Model of Coronary Artery Calcification in Atherosclerosis.
  (McGeachie M, et al. Circulation. 2009 Nov 30. [Epub ahead of print])
  View Abstract
• Incidence and progression of coronary calcification in chronic kidney disease: the Multi-Ethnic Study of Atherosclerosis.
  (Kestenbaum BR, et al. Kidney Int. 2009 Nov;76(9):991-8. Epub 2009 Aug 19.)
  View Abstract
• Intensive glucose-lowering therapy reduces cardiovascular disease events in veterans affairs diabetes trial participants with lower calcified coronary atherosclerosis.
  (Reaven PD, et al. Diabetes. 2009 Nov;58(11):2642-8. Epub 2009 Aug 3.)
  View Abstract